Related Experiment Video
Updated: May 31, 2026

A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients
Published on: August 9, 2022
Development of an extemporaneous oral liquid formulation of oxandrolone and its stability evaluation
Alka Garg1, Sanjay Garg, Richard Wong She
1National Burn Centre, Middlemore Hospital, Auckland, New Zealand. garga@middlemore.co.nz
Insights
A new stable, extemporaneous oral liquid formulation of oxandrolone was developed. This addresses the lack of suitable dosage forms, especially for pediatric patients requiring weight-based dosing.
Area of Science:
- Pharmaceutical Sciences
- Drug Formulation
- Medicinal Chemistry
Background:
- Oxandrolone is clinically valuable for muscle wasting conditions like severe burns.
- Current oxandrolone dosage forms (tablets) are unsuitable for accurate weight-based dosing, particularly in children.
- Limited guidance exists for extemporaneous oral liquid formulations of oxandrolone.
Purpose of the Study:
- To develop and validate a stable, extemporaneous oral liquid formulation of oxandrolone.
- To provide a practical alternative to existing tablet forms for accurate dosing.
- To ensure the formulation is suitable for hospital and community pharmacy settings.
Main Methods:
- Oxandrolone suspensions were prepared using New Zealand-available vehicles and ethanol.
- High-Performance Liquid Chromatography (HPLC) and Liquid Chromatography-Mass Spectrometry (LC-MS) were used for assay method development.
- Formulation stability was assessed according to International Conference on Harmonization (ICH) guidelines over 28 days.
Main Results:
- A stable extemporaneous liquid formulation of oxandrolone was successfully developed.
- The formulation utilizes crushed oxandrolone tablets dispersed in Simple Syrup BP or Orablend® vehicle.
- Confirmed stability for 21 days under evaluation.
Conclusions:
- A validated, stable oxandrolone oral liquid formulation is now available.
- This formulation offers a practical solution for accurate oxandrolone dosing, especially for pediatric use.
- The formulation can be readily prepared in pharmacy settings using accessible materials.
Abstract:
Many references exist in the literature identifying the usefulness of oxandrolone in treating muscle wasting due to various conditions including severe burns. However, there is an absence of dosage form alternatives as it is only available as tablets. The dose for children is weight based (0.1 mg/kg) which is difficult to achieve with the currently available tablets of 2.5 mg and 10 mg. The literature provides ample evidence of clinical importance but little guidance on extemporaneous oral liquid formulation of oxandrolone. In order to develop and validate an extemporaneous liquid formulation, suspensions of oxandrolone were developed using locally available (New Zealand) vehicles. Combinations of these vehicles with ethanol, as advised in some articles were also tried. Assay method was developed for oxandrolone using High Performance Liquid Chromatography (HPLC) and Mass Spectroscopy (LC-MS). The formulations were evaluated for stability as per the International Conference on Harmonization (ICH) stability guidelines. They were observed for physical and chemical stability at different time points over a period of 28 days. A stable and validated liquid formulation of oxandrolone has been developed which can be made under the hospital and community pharmacy conditions. The formula utilises commercially available oxandrolone tablets, crushed and dispersed in Simple Syrup BP or Orablend(®) vehicle. The formulation has confirmed stability for 21 days and can be easily made with locally available vehicles.
Related Concept Videos
Drug Product Stability
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Oral Drug Delivery Systems: Introduction
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
In Vitro Drug Dissolution: Compendial Testing Models I
In Vitro Drug Dissolution: Compendial Testing Models II

